Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.
Egile nagusia: | |
---|---|
Beste egile batzuk: | |
Formatua: | Thesis |
Hizkuntza: | English |
Argitaratua: |
Brac University
2024
|
Gaiak: | |
Sarrera elektronikoa: | http://hdl.handle.net/10361/23944 |